Empty Report on Ownership of Specific Securities by Executives/Major Shareholders
-
The report contains only a standard form with no actual data filled in
-
Key information such as change date, quantity change, acquisition/disposal price is all blank
-
No price-impacting factors identifiable from this disclosure
KOSDAQ Filing Information
-
Filing: Report on Ownership of Specific Securities by Executives and Major Shareholders
-
Company: Onconic Therapeutics (476060)
-
Submission: Cha Hyeon-ju
-
Receipt: 05-06-2026